Carmell Co. (NASDAQ:CTCX - Get Free Report)'s share price dropped 7.1% during trading on Monday . The company traded as low as $2.71 and last traded at $2.73. Approximately 79,873 shares traded hands during mid-day trading, a decline of 98% from the average daily volume of 3,899,615 shares. The stock had previously closed at $2.94.
Carmell Trading Down 0.4%
The firm has a 50-day moving average price of $1.34 and a two-hundred day moving average price of $0.66.
Institutional Trading of Carmell
An institutional investor recently bought a new position in Carmell stock. Antara Capital LP purchased a new stake in Carmell Co. (NASDAQ:CTCX - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 100,000 shares of the company's stock, valued at approximately $28,000. Carmell comprises 0.0% of Antara Capital LP's holdings, making the stock its 10th largest holding. Antara Capital LP owned 0.48% of Carmell at the end of the most recent reporting period. 24.22% of the stock is currently owned by institutional investors and hedge funds.
About Carmell
(
Get Free Report)
Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.
Featured Articles
Before you consider Carmell, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Carmell wasn't on the list.
While Carmell currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
